3200 Lakeside Dr.
Santa Clara , CA 95054
USA
Product Categories:
Embolic Protection Devices, Stents, Stents Drug Eluting, Vascular Closure Devices, Stents Carotid, Stents Peripheral, Stents Bare Metal
Embolic Protection Devices, Stents, Stents Drug Eluting, Vascular Closure Devices, Stents Carotid, Stents Peripheral, Stents Bare Metal
Related Content
ABSORB II Study Shows Abbott's Dissolving Heart Device Comparable to the World's Leading Heart Stent
September 24, 2014 — Abbott announced positive one-year clinical results from ABSORB II, the world's first prospective ...
September 24, 2014
Feature | Stents Bioresorbable| Dave Fornell
(UPDATE: read the Sept. 8, 2017 article "Abbott Will End Sales of Absorb Bioresorbable Stent") A key prediction for ...
September 03, 2014August 12, 2014 — The Centers for Medicare and Medicaid (CMS) took action to improve access to Abbott’s MitraClip system ...
August 12, 2014
July 29, 2014 — Mary York knew the walk from the living room to the bedroom should not have been difficult for her ...
July 29, 2014
Feature | Cardiovascular Business| Dave Fornell
As a cardiovascular technology magazine editor, I keep tabs on what technology is in development and often have the ...
May 28, 2014
May 8, 2014 — Abbott announced its catheter-based MitraClip therapy has received Health Canada approval, providing ...
May 08, 2014
April 16, 2014 — Abbott announced it has completed enrollment of three clinical trials to support approvals of the ...
April 16, 2014
April 1, 2014 — The U.S. Food and Drug Administration (FDA) approved Abbott’s Supera Peripheral Stent System to treat ...
April 01, 2014
Feature | Dave Fornell
The Cardiovascular Research Foundation’s Transcatheter Cardiovascular Therapeutics (TCT) 2013 offers many new insights ...
January 20, 2014
DAIC Editor Dave Fornell offers his choices of the most innovative new cardiovascular technologies discussed in sessions ...
November 11, 2013